Therefore, we assessed the expression of IMP3, TPX2, and PD-L1 using immunohistochemistry (IHC) and determined their potential value as molecular biomarkers for the persistent or recurrent CIN lesions after conization. This evidence concerns the gene TPX2 and cervical squamous intraepithelial neoplasia.